Etomidate
Generic Name: etomidate
Brand Names:
Etomidate
Etomidate is a sterile, nonpyrogenic solution containing 2 mg etomidate per mL with 35% propylene glycol for intravenous administration.
Overview
Etomidate is a sterile, nonpyrogenic solution containing 2 mg etomidate per mL with 35% propylene glycol for intravenous administration.
Uses
For intravenous induction of general anesthesia and supplementation of subpotent agents like nitrous oxide.
Dosage
Adults and pediatric patients over 10 years: 0.2-0.6 mg/kg IV, usual dose 0.3 mg/kg over 30-60 seconds. Geriatric patients may need reduced doses.
Side Effects
Transient venous pain (approximately 20%) and skeletal muscle movements including myoclonus (approximately 32%). Also respiratory changes, circulatory effects, and GI symptoms possible.
Warnings
Only trained personnel should administer. Not for prolonged infusion due to cortisol/aldosterone suppression risks. Pediatric neurotoxicity concerns with extended use. Contraindicated with hypersensitivity to etomidate.
Pregnancy
No adequate human studies. Animal data shows fetal concerns at certain doses. Use not recommended in obstetrics.
Frequently Asked Questions
What is Etomidate used for?▼
For intravenous induction of general anesthesia and supplementation of subpotent agents like nitrous oxide.
What are the side effects of Etomidate?▼
Transient venous pain (approximately 20%) and skeletal muscle movements including myoclonus (approximately 32%). Also respiratory changes, circulatory effects, and GI symptoms possible.
Can I take Etomidate during pregnancy?▼
No adequate human studies. Animal data shows fetal concerns at certain doses. Use not recommended in obstetrics.
What are the important warnings for Etomidate?▼
Only trained personnel should administer. Not for prolonged infusion due to cortisol/aldosterone suppression risks. Pediatric neurotoxicity concerns with extended use. Contraindicated with hypersensitivity to etomidate.
Related Medications
Tripelennamine Citrate
tripelennamine citrate
Manufactured by NOVARTIS. Dosage form: TABLET. Route: ORAL. Active ingredients: TRIPELENNAMINE HYDROCHLORIDE (50MG). Application: NDA005914.
Arnica Montana, Milk Thistle, Sus Scrofa Cerebrum, Cinchona Officinalis Bark, Ginkgo Biloba Whole, Lecithin, Soybean, Lithium Carbonate, Achillea Millefolium, Phosphoric Acid, Pork Brain, Alnus Glutinosa Whole, And Rosmarinus Officinalis Flowering Top
arnica montana, milk thistle, sus scrofa cerebrum, cinchona officinalis bark, ginkgo biloba whole, lecithin, soybean, lithium carbonate, achillea millefolium, phosphoric acid, pork brain, alnus glutinosa whole, and rosmarinus officinalis flowering top
Temporary relief of symptoms associated with mental fatigue, such as: lapses in ability to remember facts, names or words; and feelings of confusion or difficulty in collecting one's thoughts. Increases cerebral vascularisation.
Dexchlorpheniramine Maleate, Dextromethorphan Hbr, Phenylephrine Hcl
dexchlorpheniramine maleate, dextromethorphan hbr, phenylephrine hcl
Active ingredients (in each 5 mL teaspoonful) Purpose Dexchlorpheniramine Maleate 1 mg Antihistamine Dextromethorphan HBr 10 mg Cough Suppressant Phenylephrine HCl 5 mg Nasal Decongestant
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.